nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—SLCO1B1—Dextrothyroxine—hypothyroidism	0.16	0.195	CbGbCtD
Rosiglitazone—SLCO1B1—Levothyroxine—hypothyroidism	0.121	0.148	CbGbCtD
Rosiglitazone—SLCO1B1—Liothyronine—hypothyroidism	0.121	0.148	CbGbCtD
Rosiglitazone—SLCO1B1—Liotrix—hypothyroidism	0.118	0.144	CbGbCtD
Rosiglitazone—ALB—Levothyroxine—hypothyroidism	0.0663	0.081	CbGbCtD
Rosiglitazone—ALB—Liothyronine—hypothyroidism	0.0663	0.081	CbGbCtD
Rosiglitazone—ALB—Liotrix—hypothyroidism	0.0647	0.0791	CbGbCtD
Rosiglitazone—CYP2C8—Levothyroxine—hypothyroidism	0.0512	0.0626	CbGbCtD
Rosiglitazone—CYP2C8—Liotrix—hypothyroidism	0.05	0.0611	CbGbCtD
Rosiglitazone—PPARG—brown adipose tissue—hypothyroidism	0.00769	0.105	CbGeAlD
Rosiglitazone—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00566	0.0586	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0039	0.0404	CcSEcCtD
Rosiglitazone—Myocardial infarction—Liothyronine—hypothyroidism	0.00388	0.0401	CcSEcCtD
Rosiglitazone—CYP2C19—urine—hypothyroidism	0.00368	0.0501	CbGeAlD
Rosiglitazone—CYP1A2—urine—hypothyroidism	0.003	0.0409	CbGeAlD
Rosiglitazone—ACSL4—adrenal cortex—hypothyroidism	0.00287	0.0391	CbGeAlD
Rosiglitazone—CYP2C9—urine—hypothyroidism	0.00285	0.0389	CbGeAlD
Rosiglitazone—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00278	0.0288	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00278	0.0288	CcSEcCtD
Rosiglitazone—ACSL4—heart—hypothyroidism	0.00277	0.0378	CbGeAlD
Rosiglitazone—Increased appetite—Levothyroxine—hypothyroidism	0.00268	0.0278	CcSEcCtD
Rosiglitazone—Increased appetite—Dextrothyroxine—hypothyroidism	0.00268	0.0278	CcSEcCtD
Rosiglitazone—Hypertension—Liothyronine—hypothyroidism	0.00267	0.0276	CcSEcCtD
Rosiglitazone—ACSL4—cardiovascular system—hypothyroidism	0.00262	0.0357	CbGeAlD
Rosiglitazone—Cardiac failure—Levothyroxine—hypothyroidism	0.00258	0.0267	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00258	0.0267	CcSEcCtD
Rosiglitazone—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00258	0.0267	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00258	0.0267	CcSEcCtD
Rosiglitazone—Fluid retention—Liotrix—hypothyroidism	0.00243	0.0251	CcSEcCtD
Rosiglitazone—ACSL4—gonad—hypothyroidism	0.00238	0.0324	CbGeAlD
Rosiglitazone—ACSL4—pituitary gland—hypothyroidism	0.00232	0.0316	CbGeAlD
Rosiglitazone—CYP2D6—urine—hypothyroidism	0.00214	0.0292	CbGeAlD
Rosiglitazone—ACSL4—adrenal gland—hypothyroidism	0.00207	0.0282	CbGeAlD
Rosiglitazone—ACSL4—blood—hypothyroidism	0.00207	0.0282	CbGeAlD
Rosiglitazone—Cardiac failure congestive—Liotrix—hypothyroidism	0.00205	0.0212	CcSEcCtD
Rosiglitazone—ACSL4—thyroid gland—hypothyroidism	0.002	0.0272	CbGeAlD
Rosiglitazone—Increased appetite—Liotrix—hypothyroidism	0.00197	0.0204	CcSEcCtD
Rosiglitazone—ACSL4—female gonad—hypothyroidism	0.00193	0.0263	CbGeAlD
Rosiglitazone—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00192	0.0198	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00192	0.0198	CcSEcCtD
Rosiglitazone—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00191	0.0197	CcSEcCtD
Rosiglitazone—Myocardial infarction—Levothyroxine—hypothyroidism	0.00191	0.0197	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Liotrix—hypothyroidism	0.0019	0.0197	CcSEcCtD
Rosiglitazone—Cardiac failure—Liotrix—hypothyroidism	0.0019	0.0197	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Liotrix—hypothyroidism	0.00189	0.0196	CcSEcCtD
Rosiglitazone—ACSL4—testis—hypothyroidism	0.00171	0.0233	CbGeAlD
Rosiglitazone—ACSL4—liver—hypothyroidism	0.00162	0.0221	CbGeAlD
Rosiglitazone—ACSL4—cerebellum—hypothyroidism	0.00158	0.0215	CbGeAlD
Rosiglitazone—Acute coronary syndrome—Liotrix—hypothyroidism	0.00141	0.0146	CcSEcCtD
Rosiglitazone—Myocardial infarction—Liotrix—hypothyroidism	0.0014	0.0145	CcSEcCtD
Rosiglitazone—Angioedema—Levothyroxine—hypothyroidism	0.00139	0.0144	CcSEcCtD
Rosiglitazone—Angioedema—Dextrothyroxine—hypothyroidism	0.00139	0.0144	CcSEcCtD
Rosiglitazone—Arthralgia—Levothyroxine—hypothyroidism	0.00129	0.0134	CcSEcCtD
Rosiglitazone—Arthralgia—Dextrothyroxine—hypothyroidism	0.00129	0.0134	CcSEcCtD
Rosiglitazone—PPARG—heart—hypothyroidism	0.00125	0.017	CbGeAlD
Rosiglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0012	0.105	CbGpPWpGaD
Rosiglitazone—PPARG—cardiovascular system—hypothyroidism	0.00118	0.016	CbGeAlD
Rosiglitazone—ALB—heart—hypothyroidism	0.00117	0.0159	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00113	0.0117	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00113	0.0117	CcSEcCtD
Rosiglitazone—SLCO1B1—blood—hypothyroidism	0.00108	0.0147	CbGeAlD
Rosiglitazone—Fatigue—Levothyroxine—hypothyroidism	0.00107	0.0111	CcSEcCtD
Rosiglitazone—Fatigue—Dextrothyroxine—hypothyroidism	0.00107	0.0111	CcSEcCtD
Rosiglitazone—Angioedema—Liotrix—hypothyroidism	0.00102	0.0106	CcSEcCtD
Rosiglitazone—Urticaria—Dextrothyroxine—hypothyroidism	0.000985	0.0102	CcSEcCtD
Rosiglitazone—Urticaria—Levothyroxine—hypothyroidism	0.000985	0.0102	CcSEcCtD
Rosiglitazone—Hypertension—Liotrix—hypothyroidism	0.000965	0.00998	CcSEcCtD
Rosiglitazone—Arthralgia—Liotrix—hypothyroidism	0.000951	0.00984	CcSEcCtD
Rosiglitazone—PPARG—adrenal gland—hypothyroidism	0.000931	0.0127	CbGeAlD
Rosiglitazone—PPARG—blood—hypothyroidism	0.000931	0.0127	CbGeAlD
Rosiglitazone—Anaphylactic shock—Liotrix—hypothyroidism	0.000912	0.00943	CcSEcCtD
Rosiglitazone—Oedema—Liotrix—hypothyroidism	0.000912	0.00943	CcSEcCtD
Rosiglitazone—Infection—Liotrix—hypothyroidism	0.000906	0.00937	CcSEcCtD
Rosiglitazone—PPARG—thyroid gland—hypothyroidism	0.000899	0.0122	CbGeAlD
Rosiglitazone—Asthenia—Levothyroxine—hypothyroidism	0.000889	0.0092	CcSEcCtD
Rosiglitazone—Asthenia—Dextrothyroxine—hypothyroidism	0.000889	0.0092	CcSEcCtD
Rosiglitazone—PPARG—Nuclear Receptors—THRA—hypothyroidism	0.000888	0.0779	CbGpPWpGaD
Rosiglitazone—Pruritus—Dextrothyroxine—hypothyroidism	0.000877	0.00907	CcSEcCtD
Rosiglitazone—Pruritus—Levothyroxine—hypothyroidism	0.000877	0.00907	CcSEcCtD
Rosiglitazone—ALB—adrenal gland—hypothyroidism	0.000874	0.0119	CbGeAlD
Rosiglitazone—PPARG—female gonad—hypothyroidism	0.000868	0.0118	CbGeAlD
Rosiglitazone—CYP2A6—liver—hypothyroidism	0.000855	0.0117	CbGeAlD
Rosiglitazone—Diarrhoea—Levothyroxine—hypothyroidism	0.000848	0.00877	CcSEcCtD
Rosiglitazone—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000848	0.00877	CcSEcCtD
Rosiglitazone—SLCO1B1—liver—hypothyroidism	0.000844	0.0115	CbGeAlD
Rosiglitazone—CYP2A6—cerebellum—hypothyroidism	0.000835	0.0114	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000831	0.00859	CcSEcCtD
Rosiglitazone—Fatigue—Liotrix—hypothyroidism	0.000786	0.00813	CcSEcCtD
Rosiglitazone—Rash—Dextrothyroxine—hypothyroidism	0.000782	0.00809	CcSEcCtD
Rosiglitazone—Rash—Levothyroxine—hypothyroidism	0.000782	0.00809	CcSEcCtD
Rosiglitazone—Dermatitis—Levothyroxine—hypothyroidism	0.000781	0.00808	CcSEcCtD
Rosiglitazone—Dermatitis—Dextrothyroxine—hypothyroidism	0.000781	0.00808	CcSEcCtD
Rosiglitazone—Constipation—Liotrix—hypothyroidism	0.00078	0.00807	CcSEcCtD
Rosiglitazone—Headache—Dextrothyroxine—hypothyroidism	0.000777	0.00803	CcSEcCtD
Rosiglitazone—Headache—Levothyroxine—hypothyroidism	0.000777	0.00803	CcSEcCtD
Rosiglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.000775	0.068	CbGpPWpGaD
Rosiglitazone—PPARG—testis—hypothyroidism	0.00077	0.0105	CbGeAlD
Rosiglitazone—Nausea—Levothyroxine—hypothyroidism	0.000736	0.00762	CcSEcCtD
Rosiglitazone—Nausea—Dextrothyroxine—hypothyroidism	0.000736	0.00762	CcSEcCtD
Rosiglitazone—CYP2C9—heart—hypothyroidism	0.000731	0.00996	CbGeAlD
Rosiglitazone—PPARG—liver—hypothyroidism	0.000728	0.00992	CbGeAlD
Rosiglitazone—Urticaria—Liotrix—hypothyroidism	0.000724	0.00749	CcSEcCtD
Rosiglitazone—ALB—testis—hypothyroidism	0.000723	0.00984	CbGeAlD
Rosiglitazone—CYP2C19—blood—hypothyroidism	0.000703	0.00958	CbGeAlD
Rosiglitazone—PPARG—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.000702	0.0615	CbGpPWpGaD
Rosiglitazone—CYP2C9—cardiovascular system—hypothyroidism	0.00069	0.00939	CbGeAlD
Rosiglitazone—CYP2C8—pituitary gland—hypothyroidism	0.000687	0.00936	CbGeAlD
Rosiglitazone—ALB—liver—hypothyroidism	0.000683	0.00931	CbGeAlD
Rosiglitazone—PTGS1—heart—hypothyroidism	0.000667	0.00909	CbGeAlD
Rosiglitazone—Asthenia—Liotrix—hypothyroidism	0.000654	0.00677	CcSEcCtD
Rosiglitazone—Pruritus—Liotrix—hypothyroidism	0.000645	0.00667	CcSEcCtD
Rosiglitazone—PTGS1—cardiovascular system—hypothyroidism	0.00063	0.00858	CbGeAlD
Rosiglitazone—Diarrhoea—Liotrix—hypothyroidism	0.000624	0.00645	CcSEcCtD
Rosiglitazone—CYP2C8—blood—hypothyroidism	0.000614	0.00836	CbGeAlD
Rosiglitazone—Dizziness—Liotrix—hypothyroidism	0.000603	0.00624	CcSEcCtD
Rosiglitazone—Rash—Liotrix—hypothyroidism	0.000575	0.00595	CcSEcCtD
Rosiglitazone—CYP1A2—blood—hypothyroidism	0.000574	0.00783	CbGeAlD
Rosiglitazone—Dermatitis—Liotrix—hypothyroidism	0.000574	0.00594	CcSEcCtD
Rosiglitazone—PPARG—Nuclear Receptors—THRB—hypothyroidism	0.000572	0.0502	CbGpPWpGaD
Rosiglitazone—Headache—Liotrix—hypothyroidism	0.000571	0.00591	CcSEcCtD
Rosiglitazone—PTGS1—pituitary gland—hypothyroidism	0.000557	0.00759	CbGeAlD
Rosiglitazone—CYP1A2—thyroid gland—hypothyroidism	0.000554	0.00755	CbGeAlD
Rosiglitazone—CYP2C19—liver—hypothyroidism	0.00055	0.00749	CbGeAlD
Rosiglitazone—CYP2C9—blood—hypothyroidism	0.000545	0.00743	CbGeAlD
Rosiglitazone—Nausea—Liotrix—hypothyroidism	0.000542	0.0056	CcSEcCtD
Rosiglitazone—CYP2C8—testis—hypothyroidism	0.000508	0.00692	CbGeAlD
Rosiglitazone—PTGS1—adrenal gland—hypothyroidism	0.000498	0.00678	CbGeAlD
Rosiglitazone—PTGS1—blood—hypothyroidism	0.000498	0.00678	CbGeAlD
Rosiglitazone—SLCO1B1—Transport of organic anions—AVP—hypothyroidism	0.000484	0.0424	CbGpPWpGaD
Rosiglitazone—PTGS1—thyroid gland—hypothyroidism	0.00048	0.00655	CbGeAlD
Rosiglitazone—CYP2C8—liver—hypothyroidism	0.00048	0.00654	CbGeAlD
Rosiglitazone—PTGS1—female gonad—hypothyroidism	0.000464	0.00633	CbGeAlD
Rosiglitazone—PPARG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.000452	0.0397	CbGpPWpGaD
Rosiglitazone—CYP1A2—liver—hypothyroidism	0.000449	0.00612	CbGeAlD
Rosiglitazone—CYP2C9—liver—hypothyroidism	0.000426	0.00581	CbGeAlD
Rosiglitazone—PTGS1—testis—hypothyroidism	0.000412	0.00561	CbGeAlD
Rosiglitazone—CYP2D6—blood—hypothyroidism	0.000409	0.00557	CbGeAlD
Rosiglitazone—CYP2D6—female gonad—hypothyroidism	0.000382	0.0052	CbGeAlD
Rosiglitazone—CYP2D6—testis—hypothyroidism	0.000338	0.00461	CbGeAlD
Rosiglitazone—CYP2D6—liver—hypothyroidism	0.00032	0.00436	CbGeAlD
Rosiglitazone—CYP2D6—cerebellum—hypothyroidism	0.000313	0.00426	CbGeAlD
Rosiglitazone—ALB—Transport of organic anions—AVP—hypothyroidism	0.000276	0.0242	CbGpPWpGaD
Rosiglitazone—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00024	0.021	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—BGLAP—hypothyroidism	0.000223	0.0195	CbGpPWpGaD
Rosiglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.000216	0.019	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000188	0.0165	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000179	0.0157	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—IYD—hypothyroidism	0.000174	0.0152	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—SLC5A7—hypothyroidism	0.000163	0.0143	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000158	0.0139	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ATP5O—hypothyroidism	0.000148	0.013	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—TPO—hypothyroidism	0.000139	0.0122	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000129	0.0113	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000122	0.0107	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—THRA—hypothyroidism	0.000121	0.0106	CbGpPWpGaD
Rosiglitazone—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000102	0.00899	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000101	0.00889	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—ZNF764—hypothyroidism	9.06e-05	0.00794	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—NKX2-5—hypothyroidism	8.64e-05	0.00757	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—THRB—hypothyroidism	7.81e-05	0.00685	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	6.99e-05	0.00613	CbGpPWpGaD
Rosiglitazone—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.96e-05	0.0061	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—SLC5A5—hypothyroidism	6.53e-05	0.00573	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—CLTC—hypothyroidism	6.45e-05	0.00565	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—TSHB—hypothyroidism	6.44e-05	0.00564	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.22e-05	0.00545	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—AVP—hypothyroidism	6.01e-05	0.00527	CbGpPWpGaD
Rosiglitazone—PTGS1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.97e-05	0.00523	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—THRA—hypothyroidism	5.84e-05	0.00512	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	5.79e-05	0.00508	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PIK3C2A—hypothyroidism	5.74e-05	0.00503	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.66e-05	0.00496	CbGpPWpGaD
Rosiglitazone—CYP2A6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.64e-05	0.00495	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—IGF1—hypothyroidism	5.44e-05	0.00477	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—IYD—hypothyroidism	5.34e-05	0.00468	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.15e-05	0.00452	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	4.89e-05	0.00429	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—SLC5A5—hypothyroidism	4.82e-05	0.00422	CbGpPWpGaD
Rosiglitazone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.75e-05	0.00417	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ATP5O—hypothyroidism	4.54e-05	0.00398	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—TPO—hypothyroidism	4.27e-05	0.00374	CbGpPWpGaD
Rosiglitazone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.24e-05	0.00372	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—IYD—hypothyroidism	4.2e-05	0.00368	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—NKX2-5—hypothyroidism	4.16e-05	0.00365	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.95e-05	0.00347	CbGpPWpGaD
Rosiglitazone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.9e-05	0.00342	CbGpPWpGaD
Rosiglitazone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.87e-05	0.00339	CbGpPWpGaD
Rosiglitazone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.85e-05	0.00338	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	3.85e-05	0.00338	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—THRB—hypothyroidism	3.76e-05	0.0033	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—IYD—hypothyroidism	3.74e-05	0.00328	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—IGF1—hypothyroidism	3.61e-05	0.00317	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ATP5O—hypothyroidism	3.57e-05	0.00313	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	3.55e-05	0.00312	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—IYD—hypothyroidism	3.54e-05	0.0031	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	3.44e-05	0.00302	CbGpPWpGaD
Rosiglitazone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.44e-05	0.00302	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TPO—hypothyroidism	3.36e-05	0.00295	CbGpPWpGaD
Rosiglitazone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.31e-05	0.0029	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ATP5O—hypothyroidism	3.18e-05	0.00279	CbGpPWpGaD
Rosiglitazone—PTGS1—Biological oxidations—POMC—hypothyroidism	3.17e-05	0.00278	CbGpPWpGaD
Rosiglitazone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.16e-05	0.00277	CbGpPWpGaD
Rosiglitazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.14e-05	0.00275	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.11e-05	0.00273	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—VAV3—hypothyroidism	3.04e-05	0.00266	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ATP5O—hypothyroidism	3.01e-05	0.00264	CbGpPWpGaD
Rosiglitazone—CYP2A6—Biological oxidations—POMC—hypothyroidism	3e-05	0.00263	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TPO—hypothyroidism	2.99e-05	0.00262	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.94e-05	0.00258	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TPO—hypothyroidism	2.83e-05	0.00248	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	2.8e-05	0.00245	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.77e-05	0.00243	CbGpPWpGaD
Rosiglitazone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.68e-05	0.00235	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	2.6e-05	0.00228	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—POMC—hypothyroidism	2.52e-05	0.00221	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.49e-05	0.00218	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—IYD—hypothyroidism	2.41e-05	0.00212	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—IYD—hypothyroidism	2.4e-05	0.00211	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	2.2e-05	0.00193	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—IYD—hypothyroidism	2.16e-05	0.00189	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ATP5O—hypothyroidism	2.05e-05	0.0018	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—POMC—hypothyroidism	2.05e-05	0.00179	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ATP5O—hypothyroidism	2.04e-05	0.00179	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—IYD—hypothyroidism	1.98e-05	0.00174	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—TSHB—hypothyroidism	1.98e-05	0.00173	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—IYD—hypothyroidism	1.97e-05	0.00172	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.96e-05	0.00172	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SH2B3—hypothyroidism	1.95e-05	0.00171	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TPO—hypothyroidism	1.93e-05	0.00169	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TPO—hypothyroidism	1.92e-05	0.00168	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ATP5O—hypothyroidism	1.83e-05	0.00161	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—POMC—hypothyroidism	1.83e-05	0.0016	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.79e-05	0.00157	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.78e-05	0.00156	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3C2A—hypothyroidism	1.76e-05	0.00154	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.74e-05	0.00152	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TPO—hypothyroidism	1.72e-05	0.00151	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ATP5O—hypothyroidism	1.69e-05	0.00148	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—POMC—hypothyroidism	1.68e-05	0.00147	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—IYD—hypothyroidism	1.68e-05	0.00147	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ATP5O—hypothyroidism	1.67e-05	0.00147	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—POMC—hypothyroidism	1.67e-05	0.00146	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	1.6e-05	0.0014	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.6e-05	0.0014	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TPO—hypothyroidism	1.58e-05	0.00139	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TPO—hypothyroidism	1.57e-05	0.00138	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TSHB—hypothyroidism	1.56e-05	0.00136	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—SLC5A5—hypothyroidism	1.48e-05	0.0013	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.46e-05	0.00128	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ATP5O—hypothyroidism	1.43e-05	0.00125	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—POMC—hypothyroidism	1.42e-05	0.00125	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.42e-05	0.00125	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	1.39e-05	0.00122	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TSHB—hypothyroidism	1.38e-05	0.00121	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.37e-05	0.0012	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TPO—hypothyroidism	1.34e-05	0.00118	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VAV3—hypothyroidism	1.34e-05	0.00118	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TSHB—hypothyroidism	1.31e-05	0.00115	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.24e-05	0.00109	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3C2A—hypothyroidism	1.23e-05	0.00108	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.22e-05	0.00107	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3C2A—hypothyroidism	1.17e-05	0.00102	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	1.16e-05	0.00102	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	1.12e-05	0.000981	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SLC5A5—hypothyroidism	1.04e-05	0.000908	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SLC5A5—hypothyroidism	9.79e-06	0.000859	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TSHB—hypothyroidism	8.94e-06	0.000784	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TSHB—hypothyroidism	8.89e-06	0.000779	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IGF1—hypothyroidism	8.26e-06	0.000724	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TSHB—hypothyroidism	7.98e-06	0.0007	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	7.97e-06	0.000698	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3C2A—hypothyroidism	7.92e-06	0.000695	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.86e-06	0.000689	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.82e-06	0.000685	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—POMC—hypothyroidism	7.74e-06	0.000678	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TSHB—hypothyroidism	7.34e-06	0.000643	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TSHB—hypothyroidism	7.27e-06	0.000638	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	7.11e-06	0.000623	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.02e-06	0.000615	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC5A5—hypothyroidism	6.69e-06	0.000587	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC5A5—hypothyroidism	6.65e-06	0.000583	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	6.54e-06	0.000573	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	6.48e-06	0.000568	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.4e-06	0.000561	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TSHB—hypothyroidism	6.22e-06	0.000545	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—POMC—hypothyroidism	6.09e-06	0.000534	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC5A5—hypothyroidism	5.97e-06	0.000524	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	5.54e-06	0.000486	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC5A5—hypothyroidism	5.49e-06	0.000482	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.47e-06	0.000479	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC5A5—hypothyroidism	5.45e-06	0.000477	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—POMC—hypothyroidism	5.42e-06	0.000475	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—POMC—hypothyroidism	5.12e-06	0.000449	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC5A5—hypothyroidism	4.65e-06	0.000408	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—POMC—hypothyroidism	3.5e-06	0.000307	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—POMC—hypothyroidism	3.48e-06	0.000305	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—POMC—hypothyroidism	3.12e-06	0.000274	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—POMC—hypothyroidism	2.87e-06	0.000252	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—POMC—hypothyroidism	2.85e-06	0.00025	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—POMC—hypothyroidism	2.43e-06	0.000213	CbGpPWpGaD
